Skip to main content

To Build a Killing Machine

To Build a Killing Machine David Kirn can't turn his back on a century-old quest to pit oncolytic viruses against tumors. By Andrew Holtz ARTICLE EXTRAS 1 Reports like this prompted many investigators in the middle of the last century to apply viral infections to tumors, but the available viruses, either taken from the wild or adapted from contemporary vaccines, were blunt instruments. Advances in bioengineering have provided the means t

Written byAndrew Holtz
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00

David Kirn can't turn his back on a century-old quest to pit oncolytic viruses against tumors.
By Andrew Holtz

ARTICLE EXTRAS

Reports like this prompted many investigators in the middle of the last century to apply viral infections to tumors, but the available viruses, either taken from the wild or adapted from contemporary vaccines, were blunt instruments. Advances in bioengineering have provided the means to sharpen viral activity, fine tuning its targeting and adding transgenes that might aid in the destruction of cancer. Kirn is eager to get these infectious agents into humans.

On a sunny March morning, the San Francisco Bay and the Oakland Bay Bridge offer a shining view out the window, but the attention of the six staff members gathered around a conference table at Jennerex Biotherapeutics is focused on the young company's founder. Kirn, his receding hair and moustache goatee closely-cropped has his sleeves rolled up ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
Engineering Bispecific Antibodies Against Emerging Viruses

Engineering Bispecific Antibodies Against Emerging Viruses

innovative-research-horizontal-lock-inverted-rgb-900px-w-72ppi
Advancing Research With Humanized Mouse Models

Advancing Research with Next-Generation Humanized Mouse Models

bioxcell
3d illustration showing amyloid plaques in Alzheimer's disease

Best Practices for Blood-Based Amyloid Pathology Testing

fujirebio logo
Optimizing Critical Steps in T-Cell Engineering

Optimizing Critical Steps in T-Cell Engineering

Fujifilm

Products

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation

A photograph of plastic fragments floating in water, symbolizing contamination from sample storage tubes.

LVL SAFE® 2D-Coded Tubes: The Perfect Tube for Your Sample

AutoGen